Journal: Biotechnology healthcare

Article Title: Biologic Vaccines

doi:

Figure Lengend Snippet:

Article Snippet: That raises a substantial question about cost benefit, and in the United States, he says, “We are not set up to make that kind of evaluation on a population basis.” SELECTED INFECTIOUS DISEASE VACCINES IN DEVELOPMENT OR CLINICAL TRIALS Company Indication Acambis/sanofi pasteur Clostridium infections, dengue fever, Japanese encephalitis Aeras Global/GSK Tuberculosis AlphaVax Cytomegalovirus (CMV) (herpes) infections Avant Immunotherapeutics Cholera, typhoid fever Barr Pharmaceuticals/Teva Pharmaceutical Oral vaccine in FDA review for adenovirus types 4, 7 for common cold, pneumonia, bronchitis BioSante Anthrax, malaria Biogen Idec Human papillomavirus (HPV) infections DynPort Vaccine Botulism, Yersinia infections GenePhar Ebola virus, hepatitis B GenVec Coronavirus (SARS) infections, malaria Genzyme/Advinus Therapeutics Malaria GSK Dengue fever, DPT for adults, herpes, hepatitis E, malaria, meningitis, otitis media, pneumococcal infections, shingles IDRI Leishmaniasis Integrated BioTherapeutics/NIAID Ebola and Marburg viruses MedImmune Epstein-Barr virus, respiratory syncytial virus (RSV) Merck Shingles, hepatitis B, HPV, influenza, staphylococcal infections Novartis/Intercell Hepatitis A, Japanese encephalitis, pseudomonal infections sanofi pasteur CMV (herpes) infections, hepatitis B/polio/influenza combo, meningitis, meningococcal infections, rabies, tuberculosis, West Nile virus SRI International/NIAID TB, SARS, avian flu, West Nile virus, hepatitis Vical Ebola virus, West Nile virus Wyeth Pneumococcal infections in the elderly, RSV Xanodyne Pharmaceutical Urinary tract infections Open in a separate window Eighteen vaccines for prevention and/or treatment of HIV infection and 30 vaccines for prevention and/or treatment of influenza (all types) are in clinical trials.

Techniques: Vaccines, Clinical Proteomics, Virus